New diabetes clinical trial: Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

Published on: July 26, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: GLP-1 receptor agonist;   Drug: Insulin
Sponsor:   Brigham and Women's Hospital
Active, not recruiting